<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23824036</article-id><article-id pub-id-type="pmc">3688821</article-id><article-id pub-id-type="publisher-id">PONE-D-13-07263</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0065613</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Microarrays</subject></subj-group></subj-group><subj-group><subject>Model Organisms</subject><subj-group><subject>Animal Models</subject><subj-group><subject>Rat</subject></subj-group></subj-group></subj-group><subj-group><subject>Molecular Cell Biology</subject><subj-group><subject>Signal Transduction</subject><subj-group><subject>Signaling Cascades</subject></subj-group></subj-group><subj-group><subject>Gene Expression</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Geriatrics</subject></subj-group><subj-group><subject>Nephrology</subject></subj-group><subj-group><subject>Non-Clinical Medicine</subject></subj-group><subj-group><subject>Surgery</subject><subj-group><subject>Transplant Surgery</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Effects of Aging on Kidney Graft Function, Oxidative Stress and Gene Expression after Kidney Transplantation</article-title><alt-title alt-title-type="running-head">Effects of Aging on Kidney Transplantation</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xiangmei</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Di</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Ribao</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Quan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Suozhu</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Zhong</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Linlin</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Yuansheng</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">
<addr-line>State Key Laboratory of Kidney Disease, Department of Nephrology, Chinese PLA General Hospital, Beijing, P. R. China</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Sun</surname><given-names>Qinghua</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>The Ohio State University, United States of America</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>xmchen301@126.com</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: RD XC YX. Performed the experiments: RD DW RW QH SS. Analyzed the data: ZY LM. Contributed reagents/materials/analysis tools: DW RW. Wrote the paper: RD XC.</p></fn></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>18</day><month>6</month><year>2013</year></pub-date><volume>8</volume><issue>6</issue><elocation-id>e65613</elocation-id><history><date date-type="received"><day>14</day><month>2</month><year>2013</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 Ding et al</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Ding et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p>Conflicting results have been reported regarding the effects of donor age, recipient age and donor-recipient age difference on short- and long-term outcomes after kidney transplantation. The aim of this study was to evaluate the effects of recipient age on graft function, oxidative stress, and gene expression after renal transplantation. Fifty male Fischer 344 rats [25 young (Y, 4 months), 25 senior (S, 16 months)] were randomized to 6 groups: 2 sham groups (Y and S, n&#x0200a;=&#x0200a;5 in each group) and 4 renal transplant groups[young-to-young (Y-Y), young-to-senior (Y-S), senior-to-young (S-Y), senior-to-senior (S-S), (n&#x0200a;=&#x0200a;10 in each group)]. The left kidneys were transplanted from donor to recipient. After 12 weeks, systematic blood pressure, graft weight, graft function, histology and oxidative stress were measured. Microarray analysis and quantitative real-time PCR confirmation were performed to study gene expression in the grafts. There were no differences in renal graft function between young and senior kidney cross-transplantation. Transplanted kidneys showed no significant differences in glomerulosclerosis index compared to non-transplanted kidneys but had significantly different tubulointerstitium scores compared to age-matched controls. Senior rats had lower SOD activity and higher MDA content than young rats. SOD activity was significantly lower and MDA content significantly higher in the Y-S group than in the Y-Y group. There were 548 transcript differences between senior and young kidneys with 36 upregulated and 512 downregulated transcripts. There were 492 transcript differences between Y-S and Y-Y groups with 127 upregulated and 365 downregulated transcripts. There were 1244 transcript differences between the S-Y and S-S groups with 680 upregulated and 574 downregulated transcripts. Oxidative stress and gene expression profile was significantly different in the Y-S compared to the S-Y group. The identified differences were mainly in the MAPK and insulin signal pathways, making these potential targets for therapeutic intervention.</p></abstract><funding-group><funding-statement>This work was supported by grants from the National Natural Sciences Foundation of China (30901573), National Basic Research Program of China (No.2011CB944000), the Major State Basic Research Development Program of China (No.2013CB530800), National Natural Sciences Foundation of China (No.81102673), and the Nursery Foundation of PLA General Hospital (No.0712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Kidney transplant (KT) donors <xref rid="pone.0065613-Health1" ref-type="bibr">[1]</xref> and recipients <xref rid="pone.0065613-Health2" ref-type="bibr">[2]</xref> are now increasingly elderly. The growing numbers of patients with end-stage kidney disease, and improvements in short-term KT outcomes, have increased the number of patients who are at risk of the long-term complications of KT. Despite improvements in KT techniques, whether and how donor and recipient age affect graft function and patient survival after KT remain debatable. Conflicting results have been reported regarding the effects of donor age <xref rid="pone.0065613-Basar1" ref-type="bibr">[3]</xref>&#x02013;<xref rid="pone.0065613-Lim1" ref-type="bibr">[6]</xref>, recipient age <xref rid="pone.0065613-Jassal1" ref-type="bibr">[7]</xref>, <xref rid="pone.0065613-Fan1" ref-type="bibr">[8]</xref> and donor-recipient age difference <xref rid="pone.0065613-Donnelly1" ref-type="bibr">[9]</xref>, <xref rid="pone.0065613-Pascher1" ref-type="bibr">[10]</xref> on short- and long-term outcomes after KT.</p><p>Kidneys are known to be affected by the aging progress. Oxidative stress may be the most important cause of aging and aging-related disease according to the &#x0201c;double-agent&#x0201d; aging theory <xref rid="pone.0065613-Lane1" ref-type="bibr">[11]</xref>. The contribution of oxidative stress to the development of aging may be a sort of double jeopardy for outcomes after KT because older recipients of renal allografts have reduced anti-oxidative capacity, which may be associated with poorer outcome <xref rid="pone.0065613-Kolodziej1" ref-type="bibr">[12]</xref>. If transplanted kidneys age at an accelerated rate relative to other organs in the recipient, slowing or reversing this process may be a useful strategy to improve outcomes after KT. Indeed, reduced oxidative damage, as shown by reduced levels of oxidation and apoptosis, at 6 months after transplantation correlated with a better recovery of renal function in kidney allografts <xref rid="pone.0065613-LaManna1" ref-type="bibr">[13]</xref>.</p><p>In terms of kidney aging, genetic factors may influence tissue damage and the related loss of function in elderly recipients <xref rid="pone.0065613-Kainz1" ref-type="bibr">[14]</xref>. Gene expression profiling using microarrays or quantitative PCR has become a benchmark in research into novel and informative monitoring assays for KT <xref rid="pone.0065613-Brouard1" ref-type="bibr">[15]</xref>. Profiling gene expression would allow modification of post-transplant management and, thereby, potentially improve short- and long-term KT outcomes.</p><p>The aim of this study was to determine how recipient age affects oxidative stress, graft function and gene expression. We performed kidney cross-transplantation experiments in inbred rats to investigate the effects of artificially accelerated or delayed aging on the grafted kidney in the absence of inheritance and immuno-rejection effects. To avoid any effects of long-term ischemia/reperfusion injury <xref rid="pone.0065613-Tullius1" ref-type="bibr">[16]</xref>, a 12-week-long kidney cross-transplantation experiment between young and senior Fischer 344 rats was performed.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Ethics Statements</title><p>This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of PLA General Hospital, Beijing, China (Permit Number: 2009-X4-15). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.</p></sec><sec id="s2b"><title>Animal Model</title><p>Experiments were performed on 50 male Fischer 344 (Vital River Co. Beijing, China) rats (25 young [Y, 4 months, 267.9+/&#x02212;15.4 g]; 25 senior [S, 16 months, 470.6+/&#x02212;16.8 g]), we chose this kind of rat because they were an inbred strain of brothers and sisters after 20 generations without immune rejection after KT. Sham-operated rats were used as controls. Syngeneic kidney transplantation was performed between 40 male Fischer 344 rats, using the following groups (n&#x0200a;=&#x0200a;10 in each group): kidney transplants from young to senior rats (Y-S group); kidney transplants from young to young rats (Y-Y group); kidney transplants from senior to young rats (S-Y group); and kidney transplants from senoir to senior rats (S-S group). The left donor kidney was perfused with 25 U/mL of cold heparin in saline, and stored at 4&#x000b0;C prior to orthotopic transplantation. Body temperature was maintained between 36&#x000b0;C and 38&#x000b0;C during the operation. The right native kidneys of the recipients were not removed to avoid compensatory hypertrophy of the grafted kidney. Grafted kidney weight was determined before transplantation and at the end of the experiment, and systolic blood pressure was measured monthly by the tail cuff method. All rats were sacrificed at the end of 12 weeks. Kidney tissues were snap-frozen in liquid nitrogen and stored at &#x02013;70&#x000b0;C for transcriptional studies, fixed in formaldehyde for histopathological assessment.</p></sec><sec id="s2c"><title>Assessment of Renal Function</title><p>The glomerular filtration rate (GFR) was measured by the clearance of 99mTc-DTPA at the end of 12 weeks. The rats were anesthetized with 2% pentobarbital sodium (35 mg/kg) and placed under the probe of a Symbia T Radionuclide scanner (Siemens, Bonn, Germany); 1 mCi of 99mTc-DT PA was injected intravenously using an insulin syringe. The grafted kidney GFR was calculated using the Gates formula <xref rid="pone.0065613-McLigeyo1" ref-type="bibr">[17]</xref>.</p></sec><sec id="s2d"><title>Histological Examination</title><p>Formaldehyde-fixed and paraffin-embedded sections of the kidney were cut at a thickness of 2 &#x000b5;m, and stained with periodic acid Schiff (PAS). Age-related renal changes were assessed histopathologically in glomeruli and the tubulointerstitium in a blinded manner by two experienced renal pathologists who were unaware of the animal groups. Glomerulosclerosis was expressed as the percentage of globally sclerosed glomeruli based on all glomeruli present in the section. Tubulointerstitial scores were used to evaluate tissue damage: a numerical score was used to define the degree of tubular cell damage: 0, no damage; 1, unicellular, patchy, isolated necrosis; 2, tubular necrosis less than 25%; 3, tubular necrosis between 25 and 50% and 4, tubular necrosis more than 50% and presence of infracted tissue.</p></sec><sec id="s2e"><title>SA-&#x003b2;-galactosidase Staining</title><p>Frozen sections were cut at a thickness of 4 &#x000b5;m, dried for 15 min at room temperature, and then washed in PBS. Sections were fixed for 5 min in 2% formaldehyde/0.2% glutaraldehyde at room temperature. The slides were incubated overnight at 37&#x000b0;C with fresh SA-&#x003b2;-gal stain solution (2 mg/mL X-gal, 40 mM citric acid/sodium phosphate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, and 2 mM MgCl2) <xref rid="pone.0065613-Krishnamurthy1" ref-type="bibr">[18]</xref>, rinsed with PBS, counterstained with eosin, dehydrated, and mounted. SA-&#x003b2;-gal staining was quantified using Image-Pro Plus 5.1 (Media Cybernetics, Bethesda, MD) and the area of dense blue staining in the whole section was calculated.</p></sec><sec id="s2f"><title>SOD Activity and MDA Content</title><p>Kidneys were homogenized in ice-cold 20 mM Tris-HCl buffer (pH 7.4). SOD activity was determined using a commercial kit (Jiancheng Bioengineering Institute, Nanjing, China). The mauve product (nitrite) produced by oxidation of hydroxylamine has an absorbance peak at 550 nm. One unit of SOD activity was defined as the amount that reduced the absorbance at 550 nm (A550) by 50%. MDA content was determined with a commercial kit (Jiancheng Bioengineering Institute). According to the manufacturer&#x02019;s data sheet, the red product has an absorbance peak at 532 nm (A532) <xref rid="pone.0065613-Sasaki1" ref-type="bibr">[19]</xref>.</p></sec><sec id="s2g"><title>Microarray Analysis</title><p>Total RNA was extracted from kidney samples using Trizol Reagent according to the protocol (Invitrogen, Carlsbad, CA). RNA quality was checked by Northern blotting. Microarray analysis was performed by CapitalBio Corp. (Beijing, China) using rat genome-wide oligonucleotide microarrays according to the methods described previously <xref rid="pone.0065613-Guo1" ref-type="bibr">[20]</xref>, <xref rid="pone.0065613-Patterson1" ref-type="bibr">[21]</xref>. Briefly, a Rattus norvegicus genome oligonucleotide set (from Operon oligo database, Rat Genome version 3.0.5, details was opened in <ext-link ext-link-type="uri" xlink:href="http://www.Operon.com">http://www.Operon.com</ext-link>), consisting of 26962 5&#x02032; amino acid modified 70-mer probes representing 22012 genes and 27044 gene transcripts, was purchased from Operon (Huntsville, AL) and printed on glass slides using a SmartArray&#x02122; microarrayer (CapitalBio). Aliquots of 5 &#x000b5;g DNase-treated total RNA were prepared and fluorescent dye (Cy5 and Cy3-dCTP)-labeled cDNA was produced using Eberwine&#x02019;s linear RNA amplification method <xref rid="pone.0065613-VanGelder1" ref-type="bibr">[22]</xref>, and followed by hybridization. Finally, arrays were scanned with a confocal LuxScan&#x02122; scanner (CapitalBio), and the data were extracted with SpotData software (CapitalBio). Space- and intensity-dependent normalization based on the LOWESS program was employed <xref rid="pone.0065613-Yang1" ref-type="bibr">[23]</xref>. Genes with a Cy3 or Cy5 signal intensity greater than 800 were considered as expressed. For each sample, two hybridizations were performed using a reversal fluorescent strategy. Those genes for which the expression patterns remained consistent in both arrays and the mean expression ratios averaged above twofold were selected as differentially expressed genes.</p></sec><sec id="s2h"><title>Quantitative Real-time PCR</title><p>To confirm the microarray results, four representative genes (SIRT-1, connexin43, Irak2 and M6pr) were analyzed by quantitative real-time PCR, according to a modified method <xref rid="pone.0065613-Guo1" ref-type="bibr">[20]</xref>, cDNA was prepared from 2 &#x000b5;g DNase-treated total RNA from each sample using a First Strand SuperScript II Kit (Invitrogen). Quantitative real-time PCR was performed using a DNA Master SYBR Green I Kit and LightCycler (Roche Diagnostics, Mannheim, Germany), in accordance with the protocols, and the results were analyzed using LightCycler software version 3.5 (Roche Diagnostics). Single PCR products were further verified by melting curve analysis and 1.2% agarose gel electrophoresis. Each gene of interest was normalized relative to &#x003b2;-actin. In addition, each amplification reaction was performed in duplicate, and the mean value was calculated. The mathematical model reported by Pfaffl <xref rid="pone.0065613-Pfaffl1" ref-type="bibr">[24]</xref> was employed to analyze the relative expression ratios of these genes. Primers used for the quantitative real-time PCR are listed in <xref ref-type="table" rid="pone-0065613-t001">Table 1</xref>.</p><table-wrap id="pone-0065613-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.t001</object-id><label>Table 1</label><caption><title>Genes selected and primer choices fo<italic>r qRT&#x02013;PCR.</italic>
</title></caption><alternatives><graphic id="pone-0065613-t001-1" xlink:href="pone.0065613.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">
<italic>GB ac</italic>cession no.</td><td align="left" rowspan="1" colspan="1">Gene symbol</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sequence (5&#x02032;to 3&#x02032;)</td><td align="left" rowspan="1" colspan="1">Amplification size</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">NM_012567</td><td align="left" rowspan="1" colspan="1">Cx43</td><td align="left" rowspan="1" colspan="1">F</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TCTGAGTCCTCCACATAGCG</named-content>
</td><td align="left" rowspan="1" colspan="1">278</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GAAGGCACAAAGGTGAGACA</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NM_001107627</td><td align="left" rowspan="1" colspan="1">SIRT1</td><td align="left" rowspan="1" colspan="1">F</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AATATCCTTTCAGAACCACCAA</named-content>
</td><td align="left" rowspan="1" colspan="1">173</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AGGCGAGCATAAATACCATCT</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NM_001025422</td><td align="left" rowspan="1" colspan="1">Irak2</td><td align="left" rowspan="1" colspan="1">F</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TACGGGCTCATCTTCTAATACC</named-content>
</td><td align="left" rowspan="1" colspan="1">80</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CCATAACAGAAGAGGGGACAC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">BC079226</td><td align="left" rowspan="1" colspan="1">M6pr</td><td align="left" rowspan="1" colspan="1">F</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GTTGGGAGAATCAACGAGACTC</named-content>
</td><td align="left" rowspan="1" colspan="1">104</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CGCTGTTCTTTGCCACAGTG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NM_031144.2</td><td align="left" rowspan="1" colspan="1">Actin</td><td align="left" rowspan="1" colspan="1">F</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GTACCCAGGCATTGCTGACA</named-content>
</td><td align="left" rowspan="1" colspan="1">169</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTCCTGCTTGCTGATCCACATC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap></sec><sec id="s2i"><title>Statistics</title><p>All data are presented as mean &#x000b1; SD. SPSS 11.0 was used to determine statistical significance. Variables were analyzed using a one-way ANOVA, once the difference found, a Tukey-Kramer multiple comparisons test was used to compare among groups. Differences were considered as statistically significant when p was less than 0.05. LuxScan 3.0 image analysis software and Significant Analysis of Microarray (SAM) software were used to analyze the microarray data <xref rid="pone.0065613-Tusher1" ref-type="bibr">[25]</xref>. CapitalBio&#x000ae; Molecule Annotation System V4.0 (MAS) was used to annotate and analyze the differentially expressed genes.</p></sec></sec><sec id="s3"><title>Results</title><p>Senior rats had slightly higher systolic blood pressure (SBP; mmHg) than young rats, and this was not affected by transplantation (<xref ref-type="table" rid="pone-0065613-t002">Table 2</xref>). The S-Y group had a slightly higher GFR than the S-S group, and the Y-S group had a slightly lower GFR than the Y-Y group, but the differences were not significant (<xref ref-type="table" rid="pone-0065613-t002">Table 2</xref>).</p><table-wrap id="pone-0065613-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.t002</object-id><label>Table 2</label><caption><title>Body weight, kidney weight, systolic blood pressure (SBP), glomerular filtration rate (GFR), glomerulosclerosis index, tubulo-interstitum scores, SA-&#x003b2;-gal positive rate, superoxide dismutase (SOD) activity and malondialdehyde (MDA) content in the different groups.</title></caption><alternatives><graphic id="pone-0065613-t002-2" xlink:href="pone.0065613.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Y</td><td align="left" rowspan="1" colspan="1">Y-Y</td><td align="left" rowspan="1" colspan="1">Y-S</td><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">S-S</td><td align="left" rowspan="1" colspan="1">S-Y</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Body weight (g)</td><td align="left" rowspan="1" colspan="1">341.9&#x000b1;21.4</td><td align="left" rowspan="1" colspan="1">329.6&#x000b1;13.3</td><td align="left" rowspan="1" colspan="1">320.0&#x000b1;20.7</td><td align="left" rowspan="1" colspan="1">523.9&#x000b1;26.2<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">511.5&#x000b1;22.7<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">527.4&#x000b1;24.8<xref ref-type="table-fn" rid="nt101">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Kidney weight (g)</td><td align="left" rowspan="1" colspan="1">0.93&#x000b1;0.02</td><td align="left" rowspan="1" colspan="1">0.92&#x000b1;0.02</td><td align="left" rowspan="1" colspan="1">0.92&#x000b1;0.02</td><td align="left" rowspan="1" colspan="1">1.20&#x000b1;0.06<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">1.23&#x000b1;0.06 <xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">1.21&#x000b1;0.07<xref ref-type="table-fn" rid="nt101">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP (mmHg)</td><td align="left" rowspan="1" colspan="1">104.6&#x000b1;1.7</td><td align="left" rowspan="1" colspan="1">105.3&#x000b1;2.4</td><td align="left" rowspan="1" colspan="1">104.2&#x000b1;2.1</td><td align="left" rowspan="1" colspan="1">109.2&#x000b1;1.9</td><td align="left" rowspan="1" colspan="1">109.1&#x000b1;2.2</td><td align="left" rowspan="1" colspan="1">107.8&#x000b1;1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR (mL/min)</td><td align="left" rowspan="1" colspan="1">1.39&#x000b1;0.21</td><td align="left" rowspan="1" colspan="1">1.35&#x000b1;0.19</td><td align="left" rowspan="1" colspan="1">1.29&#x000b1;0.25</td><td align="left" rowspan="1" colspan="1">1.30&#x000b1;0.31<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">1.27&#x000b1;0.23<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">1.32&#x000b1;0.24<xref ref-type="table-fn" rid="nt101">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Glomerulosclerosis index</td><td align="left" rowspan="1" colspan="1">0.05&#x000b1;0.00</td><td align="left" rowspan="1" colspan="1">0.05&#x000b1;0.01</td><td align="left" rowspan="1" colspan="1">0.06&#x000b1;0.00</td><td align="left" rowspan="1" colspan="1">0.29&#x000b1;0.03<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.33&#x000b1;0.02<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.31&#x000b1;0.02<xref ref-type="table-fn" rid="nt101">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Tubulo-interstitum scores</td><td align="left" rowspan="1" colspan="1">0.08&#x000b1;0.07</td><td align="left" rowspan="1" colspan="1">0.23&#x000b1;0.08<xref ref-type="table-fn" rid="nt103">&#x00026;</xref>
</td><td align="left" rowspan="1" colspan="1">0.30&#x000b1;0.05<xref ref-type="table-fn" rid="nt103">&#x00026;</xref>
</td><td align="left" rowspan="1" colspan="1">0.65&#x000b1;0.10 <xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.97&#x000b1;0.17<xref ref-type="table-fn" rid="nt103">&#x00026;</xref>
</td><td align="left" rowspan="1" colspan="1">0.87&#x000b1;0.11<xref ref-type="table-fn" rid="nt103">&#x00026;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">SA-&#x003b2;-gal positive rate (%)</td><td align="left" rowspan="1" colspan="1">0.03&#x000b1;0.01</td><td align="left" rowspan="1" colspan="1">0.30&#x000b1;0.09<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.42&#x000b1;0.07<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt102">&#x000a7;</xref>
</td><td align="left" rowspan="1" colspan="1">4.48&#x000b1;1.39<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">6.13&#x000b1;1.34<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt103">&#x00026;</xref>
</td><td align="left" rowspan="1" colspan="1">4.63&#x000b1;0.80<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt104">$</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">SOD (U/mg protein)</td><td align="left" rowspan="1" colspan="1">48.6&#x000b1;7.5</td><td align="left" rowspan="1" colspan="1">43.5&#x000b1;6.2</td><td align="left" rowspan="1" colspan="1">36.8&#x000b1;3.6<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt102">&#x000a7;</xref>
</td><td align="left" rowspan="1" colspan="1">35.4&#x000b1;3.5<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">29.4&#x000b1;4.1<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt103">&#x00026;</xref>
</td><td align="left" rowspan="1" colspan="1">43.1&#x000b1;5.7<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt104">$</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MDA (nmol/mg protein)</td><td align="left" rowspan="1" colspan="1">1.82&#x000b1;0.41</td><td align="left" rowspan="1" colspan="1">2.03&#x000b1;0.52</td><td align="left" rowspan="1" colspan="1">2.65&#x000b1;0.46<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt102">&#x000a7;</xref>
</td><td align="left" rowspan="1" colspan="1">2.73&#x000b1;0.48<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1">3.64&#x000b1;0.51<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt103">&#x00026;</xref>
</td><td align="left" rowspan="1" colspan="1">2.21&#x000b1;0.47<xref ref-type="table-fn" rid="nt101">*</xref>
<xref ref-type="table-fn" rid="nt104">$</xref>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>*</label><p>,P&#x0003c;0.01, vs Y;</p></fn><fn id="nt102"><label>&#x000a7;</label><p>,P&#x0003c;0.05, vs YY;</p></fn><fn id="nt103"><label>&#x00026;</label><p>,P&#x0003c;0.05, vs S;</p></fn><fn id="nt104"><label>$</label><p>,P&#x0003c;0.05, vs SS.</p></fn></table-wrap-foot></table-wrap><p>SA-&#x003b2;-gal is a simple biomarker of replicative senescence. The positive rate of staining for SA-&#x003b2;-gal was significantly higher in senior compared to young kidneys, and levels were significantly higher in the Y-S group than in the Y-Y group; in addition, levels were significantly lower in the S-Y group compared to those in the S-S group (<xref ref-type="fig" rid="pone-0065613-g001">Fig. 1</xref>, <xref ref-type="table" rid="pone-0065613-t002">Table 2</xref>).</p><fig id="pone-0065613-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.g001</object-id><label>Figure 1</label><caption><title>SA-&#x003b2;-gal staining of kidney tissues (&#x000d7;100).</title></caption><graphic xlink:href="pone.0065613.g001"/></fig><p>Senior rats had lower SOD activity and higher MDA content than young rats (<xref ref-type="table" rid="pone-0065613-t002">Table 2</xref>). SOD activity was significantly lower and MDA content significantly higher in the Y-S group than in the Y-Y group (<xref ref-type="table" rid="pone-0065613-t002">Table 2</xref>). However, SOD activity was significantly higher and MDA content significantly lower in the S-Y group than in the S-S group (<xref ref-type="table" rid="pone-0065613-t002">Table 2</xref>).</p><sec id="s3a"><title>Histopathology</title><p>Young sham-operated rats had normal renal histology, but the kidneys of senior sham-operated rats had age-related changes (<xref ref-type="fig" rid="pone-0065613-g002">Fig. 2</xref>) with glomeruli showing various degrees of glomerulosclerosis, mesangial matrix expansion, and thickening of the glomerular capillary basement membrane. There was also pronounced tubulointerstitial injury, with some areas showing tubular dilation, cast formation, tubular atrophy, thickening, splitting of tubular basement membranes, widening of the interstitium with fibrosis, and loss of focal peritubular capillaries. Transplanted kidneys showed no significant differences in glomerulosclerosis index compared to age-matched controls but had significantly greater tubule-interstitium scores (P&#x0003c;0.05) (<xref ref-type="table" rid="pone-0065613-t002">Table 2</xref>).</p><fig id="pone-0065613-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.g002</object-id><label>Figure 2</label><caption><title>Periodic acid Schiff (PAS) staining of kidney tissues (&#x000d7;100).</title></caption><graphic xlink:href="pone.0065613.g002"/></fig></sec><sec id="s3b"><title>Renal Transcriptional Changes with Age</title><p>There were 548 differentially expressed transcripts in young and senior rat kidneys, including 36 that were upregulated and 512 downregulated (<xref ref-type="table" rid="pone-0065613-t003">Table 3</xref>). Using the Kyoto Encyclopedia of Genes and Genomes (KEGG), pathway analysis showed that the genes were clustered in the following pathways: Mitogen-activated protein kinase (MAPK) signaling pathway (8/218, the first number indicates the number of genes changed in this pathway, and the second number how many genes are involved in this pathway), tight junction (7/110), and insulin signaling pathway (6/113) (<xref ref-type="table" rid="pone-0065613-t003">Tables 3</xref>&#x00026;<xref ref-type="table" rid="pone-0065613-t004">4</xref>&#x00026;<xref ref-type="table" rid="pone-0065613-t005">5</xref>).</p><table-wrap id="pone-0065613-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.t003</object-id><label>Table 3</label><caption><title>Gene expression profile in the different pathways among groups.</title></caption><alternatives><graphic id="pone-0065613-t003-3" xlink:href="pone.0065613.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td colspan="2" align="left" rowspan="1"/><td align="left" rowspan="1" colspan="1">S vs Y</td><td align="left" rowspan="1" colspan="1">Y-S</td><td align="left" rowspan="1" colspan="1">S-Y</td></tr></thead><tbody><tr><td colspan="2" align="left" rowspan="1">Total gene expression change</td><td align="left" rowspan="1" colspan="1">548</td><td align="left" rowspan="1" colspan="1">492</td><td align="left" rowspan="1" colspan="1">1244</td></tr><tr><td colspan="2" align="left" rowspan="1">Up-regulation/down-regulation</td><td align="left" rowspan="1" colspan="1">36/512</td><td align="left" rowspan="1" colspan="1">127/365</td><td align="left" rowspan="1" colspan="1">680/574</td></tr><tr><td align="left" rowspan="1" colspan="1">Up-regulated pathways</td><td align="left" rowspan="1" colspan="1">MAPK</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">cPDA2, ATF-2</td><td align="left" rowspan="1" colspan="1">TGFB, MEKK1, GADD153, MKP,cPDA2, HSP72, c-Myc, ARRB</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">insulin signaling</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AMPK, FOXO1, GSK-3&#x003b2;,4EBP1, HSL, PHK</td></tr><tr><td align="left" rowspan="1" colspan="1">Down-regulated pathways</td><td align="left" rowspan="1" colspan="1">MAPK</td><td align="left" rowspan="1" colspan="1">Rap1, ERK, MKP, OLK, ATF-2,CASP, MST1/2, TGFB</td><td align="left" rowspan="1" colspan="1">ERK, TGFB, c-JUN,Cdc42/Rac</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">tightjunction</td><td align="left" rowspan="1" colspan="1">Claudins, PALS1, G&#x003b1;, VAP33,JAM, PP2A, MAGI2/3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">insulin signaling</td><td align="left" rowspan="1" colspan="1">AMPK, ACC, G6PC, PP1,ERK1/2, eIF4E</td><td align="left" rowspan="1" colspan="1">G6PC, PHK,ERK1/2</td><td align="left" rowspan="1" colspan="1">G6PC, eIF4E, PEPCK</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone-0065613-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.t004</object-id><label>Table 4</label><caption><title>Gene up/down-regulation in the young kidneys transplanted into the senior recipient (YS vs YY) compared with the young recipient.</title></caption><alternatives><graphic id="pone-0065613-t004-4" xlink:href="pone.0065613.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Up/down</td><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Definition</td><td align="left" rowspan="1" colspan="1">description</td><td align="left" rowspan="1" colspan="1">GB accession</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Up-regulation</td><td align="left" rowspan="1" colspan="1">Ehd4</td><td align="left" rowspan="1" colspan="1">EH-domain containing 4</td><td align="left" rowspan="1" colspan="1">GTP binding; guanyl nucleotide binding</td><td align="left" rowspan="1" colspan="1">BC083175</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Atn1</td><td align="left" rowspan="1" colspan="1">atrophin 1</td><td align="left" rowspan="1" colspan="1">Neurodegenerative Disorders; system development; nervous system development; Dentatorubropallidoluysian atrophy (DRPLA)</td><td align="left" rowspan="1" colspan="1">U31777</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Matn1</td><td align="left" rowspan="1" colspan="1">matrilin 1, cartilage matrix protein</td><td align="left" rowspan="1" colspan="1">extracellular matrix; extracellular matrix</td><td align="left" rowspan="1" colspan="1">BC083869</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cfb</td><td align="left" rowspan="1" colspan="1">complement component 2</td><td align="left" rowspan="1" colspan="1">chymotrypsin activity; serine-type peptidase activity; response toexternal biotic stimulus; response to pest, pathogen or parasite;trypsin activity; extracellular region; response to external stimulus;serine-type endopeptidase activity; peptidase activity</td><td align="left" rowspan="1" colspan="1">BC070923</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Itgb7</td><td align="left" rowspan="1" colspan="1">integrin, beta 7</td><td align="left" rowspan="1" colspan="1">Cell adhesion molecules (CAMs); Regulation of actin cytoskeleton; cell adhesion;Focal adhesion; integral to plasma membrane; intrinsic to plasma membrane;Integrin-mediated cell adhesion KEGG; ECM-recipient interaction</td><td align="left" rowspan="1" colspan="1">AF003598</td></tr><tr><td align="left" rowspan="1" colspan="1">Down-regulation</td><td align="left" rowspan="1" colspan="1">Ptk9</td><td align="left" rowspan="1" colspan="1">protein tyrosine kinase 9</td><td align="left" rowspan="1" colspan="1">actin binding; cytoskeletal protein binding; kinase activity</td><td align="left" rowspan="1" colspan="1">BC086536</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Vapa</td><td align="left" rowspan="1" colspan="1">vesicle-associated membrane protein, associated protein a</td><td align="left" rowspan="1" colspan="1">Rn-Circadian-Exercise; structural molecule activity; Tight junction</td><td align="left" rowspan="1" colspan="1">BC061875</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Eif1a</td><td align="left" rowspan="1" colspan="1">eukaryotic translationinitiation factor 1A</td><td align="left" rowspan="1" colspan="1">be required for maximal rate of protein biosynthesis</td><td align="left" rowspan="1" colspan="1">NM_001008773</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ddx19</td><td align="left" rowspan="1" colspan="1">DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a</td><td align="left" rowspan="1" colspan="1">plays a role in zinc induced apoptosis; ATPase activity, coupled; ATPase activity</td><td align="left" rowspan="1" colspan="1">BC079094</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nox4</td><td align="left" rowspan="1" colspan="1">NADPH oxidase 4</td><td align="left" rowspan="1" colspan="1">oxidoreductase activity; electron transport</td><td align="left" rowspan="1" colspan="1">AY027527</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dab2</td><td align="left" rowspan="1" colspan="1">disabled homolog 2</td><td align="left" rowspan="1" colspan="1">cellular morphogenesis; morphogenesis; negative regulation of cellular physiological process; negative regulation of cellular process</td><td align="left" rowspan="1" colspan="1">U95177</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">F13b</td><td align="left" rowspan="1" colspan="1">coagulation factor XIII,beta subunit</td><td align="left" rowspan="1" colspan="1">Steroid Biosynthesis; Complement and Coagulation Cascades</td><td align="left" rowspan="1" colspan="1">CO563315</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sgk</td><td align="left" rowspan="1" colspan="1">serum/glucocorticoidregulated kinase</td><td align="left" rowspan="1" colspan="1">protein serine threonine kinase activity;apoptosis; Insulin Signaling</td><td align="left" rowspan="1" colspan="1">L01624</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Gatm</td><td align="left" rowspan="1" colspan="1">glycineamidinotransferase</td><td align="left" rowspan="1" colspan="1">Urea cycle and metabolism of amino groups; mitochondrion;Urea cycle and metabolism of amino groups; Arginine and prolinemetabolism; Glycine, serine and threonine metabolism</td><td align="left" rowspan="1" colspan="1">BC081785</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Kif21a</td><td align="left" rowspan="1" colspan="1">kinesin family member 21A</td><td align="left" rowspan="1" colspan="1">microtubule cytoskeleton; cytoskeleton organization and biogenesis; motor activity</td><td align="left" rowspan="1" colspan="1">XM_217022</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G6pc</td><td align="left" rowspan="1" colspan="1">glucose-6-phosphatase</td><td align="left" rowspan="1" colspan="1">phosphoric monoester hydrolase activity; cytosol; energy derivation by oxidation of organic compounds; endoplasmic reticulum; peptidase activity; Proteasome Degradation; phosphoric ester hydrolase activity; Adipocytokine signaling pathway; Starch and sucrose metabolism; Glycolysis and Gluconeogenesis; Insulin signaling pathway; Galactose metabolism; Glycolysis/Gluconeogenesis</td><td align="left" rowspan="1" colspan="1">BC090067</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Lgals8</td><td align="left" rowspan="1" colspan="1">lectin, galactose binding, soluble 8</td><td align="left" rowspan="1" colspan="1">sugar binding; carbohydrate binding</td><td align="left" rowspan="1" colspan="1">BC072488</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nqo2</td><td align="left" rowspan="1" colspan="1">NAD(P)H dehydrogenase, quinone 2</td><td align="left" rowspan="1" colspan="1">oxidoreductase activity; electron transport</td><td align="left" rowspan="1" colspan="1">BC079157</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dr1</td><td align="left" rowspan="1" colspan="1">down-regulator oftranscription 1</td><td align="left" rowspan="1" colspan="1">Transcription</td><td align="left" rowspan="1" colspan="1">BC083822</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Tmem86a</td><td align="left" rowspan="1" colspan="1">transmembraneprotein 86A</td><td align="left" rowspan="1" colspan="1">Ribosome; Celera Assembly; genome assembly; Cytogenetic</td><td align="left" rowspan="1" colspan="1">XM_218592</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Atf2</td><td align="left" rowspan="1" colspan="1">activating transcriptionfactor 2</td><td align="left" rowspan="1" colspan="1">MAPK signaling pathway; system development;nervous system development; MAPK signaling pathway; p38 MAPK signalingpathway; Smooth muscle contraction; transcription</td><td align="left" rowspan="1" colspan="1">U38938</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Hsd17b1</td><td align="left" rowspan="1" colspan="1">Hsd17b1</td><td align="left" rowspan="1" colspan="1">lipid biosynthesis; metabolism; oxidoreductase activity; Steroid Biosynthesis;Androgen and estrogen metabolism; cytoplasm</td><td align="left" rowspan="1" colspan="1">BC086365</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frg1</td><td align="left" rowspan="1" colspan="1">similar to FSHDregion gene 1</td><td align="left" rowspan="1" colspan="1">transporter activity; binding</td><td align="left" rowspan="1" colspan="1">CF977214</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Gtf2f2</td><td align="left" rowspan="1" colspan="1">general transcriptionfactor IIF,polypeptide 2</td><td align="left" rowspan="1" colspan="1">RNA transcription Reactome; positive regulation of cellular process; Basal transcription factors; transcription; positive regulation of cellular physiological process</td><td align="left" rowspan="1" colspan="1">D10665</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Agtr1a</td><td align="left" rowspan="1" colspan="1">angiotensin II recipient,type 1 (AT1A)</td><td align="left" rowspan="1" colspan="1">Calcium signaling pathway; Neuroactive ligand-recipient interaction; rhodopsin-like recipient activity; GPCRDB Class A Rhodopsin-like; Peptide GPCRs</td><td align="left" rowspan="1" colspan="1">BC078810</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M6pr</td><td align="left" rowspan="1" colspan="1">cation-dependentmannose-6-phosphaterecipient</td><td align="left" rowspan="1" colspan="1">sugar binding; carbohydrate binding</td><td align="left" rowspan="1" colspan="1">BC079226</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Irak2</td><td align="left" rowspan="1" colspan="1">interleukin-1 recipient -associated kinase 2</td><td align="left" rowspan="1" colspan="1">Apoptosis; protein serine threonine kinase activity; protein-tyrosine kinase activity</td><td align="left" rowspan="1" colspan="1">NM_001025422</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Car12</td><td align="left" rowspan="1" colspan="1">carbonic anyhydrase 12</td><td align="left" rowspan="1" colspan="1">lyase activity</td><td align="left" rowspan="1" colspan="1">XM_343416</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Snapc2</td><td align="left" rowspan="1" colspan="1">small nuclear RNAactivating complex,polypeptide 2</td><td align="left" rowspan="1" colspan="1">Transcription</td><td align="left" rowspan="1" colspan="1">BC079077</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone-0065613-t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.t005</object-id><label>Table 5</label><caption><title>Gene up/down-regulation in the senior kidneys while transplanted into the senior recipient compared with the young recipient.</title></caption><alternatives><graphic id="pone-0065613-t005-5" xlink:href="pone.0065613.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Up/down</td><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Definition</td><td align="left" rowspan="1" colspan="1">description</td><td align="left" rowspan="1" colspan="1">GB accession</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Up-regulation</td><td align="left" rowspan="1" colspan="1">Matn1</td><td align="left" rowspan="1" colspan="1">matrilin 1, cartilage matrix protein</td><td align="left" rowspan="1" colspan="1">extracellular matrix; extracellular matrix</td><td align="left" rowspan="1" colspan="1">BC083869</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cfb</td><td align="left" rowspan="1" colspan="1">complement component 2</td><td align="left" rowspan="1" colspan="1">chymotrypsin activity; serine-type peptidase activity; response to external biotic stimulus; response to pest, pathogen or parasite; trypsin activity; extracellular region; response to external stimulus; serine-type endopeptidase activity; peptidase activity</td><td align="left" rowspan="1" colspan="1">BC070923</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Mcm6</td><td align="left" rowspan="1" colspan="1">mini chromosome maintenance deficient 6 (S. cerevisiae)</td><td align="left" rowspan="1" colspan="1">ATPase activity; cell cycle; transcription; ATPase activity, coupled</td><td align="left" rowspan="1" colspan="1">U17565</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">V1ra13</td><td align="left" rowspan="1" colspan="1">vomeronasal 1 recipient, a13</td><td align="left" rowspan="1" colspan="1">rhodopsin-like recipient activity</td><td align="left" rowspan="1" colspan="1">AY510286</td></tr><tr><td align="left" rowspan="1" colspan="1">Down-regulation</td><td align="left" rowspan="1" colspan="1">Sdfr1</td><td align="left" rowspan="1" colspan="1">stromal cell derived factor recipient 1</td><td align="left" rowspan="1" colspan="1">sugar binding; carbohydrate binding</td><td align="left" rowspan="1" colspan="1">X99338</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dek</td><td align="left" rowspan="1" colspan="1">DEK oncogene</td><td align="left" rowspan="1" colspan="1">RNA binding; secretory pathway; GTP binding; guanyl nucleotide binding; intracellular protein transport; secretion</td><td align="left" rowspan="1" colspan="1">BC079344</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Serinc1</td><td align="left" rowspan="1" colspan="1">serine incorporator 1</td><td align="left" rowspan="1" colspan="1">RNA binding</td><td align="left" rowspan="1" colspan="1">AY539942</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Mat2a</td><td align="left" rowspan="1" colspan="1">Methionine adenosyltransferase II</td><td align="left" rowspan="1" colspan="1">magnesium ion binding; selenoamino acid metabolism; methionine metabolism</td><td align="left" rowspan="1" colspan="1">BC062394</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Golph3</td><td align="left" rowspan="1" colspan="1">golgi phosphoprotein 3</td><td align="left" rowspan="1" colspan="1">Golgi stack; Golgi apparatus</td><td align="left" rowspan="1" colspan="1">AF311954</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Adss</td><td align="left" rowspan="1" colspan="1">adenylosuccinate synthetase 2</td><td align="left" rowspan="1" colspan="1">ligase activity, forming carbon-nitrogen bonds; GTP binding; guanyl nucleotide binding</td><td align="left" rowspan="1" colspan="1">XM_222946</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cyp2c</td><td align="left" rowspan="1" colspan="1">Cytochrome P450, subfamily IIC (mephenytoin 4 -hydroxylase)</td><td align="left" rowspan="1" colspan="1">iron ion binding; electron transport; tetrapyrrole binding; membrane fraction; heme binding; cell fraction; endoplasmic reticulum</td><td align="left" rowspan="1" colspan="1">BC088146</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ssr3</td><td align="left" rowspan="1" colspan="1">signal sequence recipient, gamma</td><td align="left" rowspan="1" colspan="1">secretory pathway; intracellular protein transport; endoplasmic reticulum; secretion; organelle membrane</td><td align="left" rowspan="1" colspan="1">BC062015</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TM9SF3</td><td align="left" rowspan="1" colspan="1">transmembrane 9 superfamily member 3</td><td align="left" rowspan="1" colspan="1">transporter activity</td><td align="left" rowspan="1" colspan="1">XM_220013</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cept1</td><td align="left" rowspan="1" colspan="1">choline/ethanolamine phosphotransferase 1</td><td align="left" rowspan="1" colspan="1">lipid biosynthesis</td><td align="left" rowspan="1" colspan="1">BC079471</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Arl8b</td><td align="left" rowspan="1" colspan="1">ADP-ribosylation factor-like 8B</td><td align="left" rowspan="1" colspan="1">GTP binding; guanyl nucleotide binding; intracellular protein transport; small GTPase mediated signal transduction</td><td align="left" rowspan="1" colspan="1">BC081947</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Pcaf</td><td align="left" rowspan="1" colspan="1">p300/CBP-associated factor</td><td align="left" rowspan="1" colspan="1">Notch signaling pathway</td><td align="left" rowspan="1" colspan="1">NM_001024252</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dnajc10</td><td align="left" rowspan="1" colspan="1">DnaJ (Hsp40) homolog, subfamily C, member 10</td><td align="left" rowspan="1" colspan="1">electron transport; protein folding; electron transporter activity</td><td align="left" rowspan="1" colspan="1">XM_215751</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Pls3</td><td align="left" rowspan="1" colspan="1">plastin 3</td><td align="left" rowspan="1" colspan="1">actin binding; cytoskeleton organization and biogenesis; cytoskeletal protein binding</td><td align="left" rowspan="1" colspan="1">X70706</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Arl6ip2</td><td align="left" rowspan="1" colspan="1">ADP-ribosylation factor-like 6 interacting protein 2</td><td align="left" rowspan="1" colspan="1">GTP binding; guanyl nucleotide binding; response to biotic stimulus</td><td align="left" rowspan="1" colspan="1">XM_216629</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Eif4e</td><td align="left" rowspan="1" colspan="1">eukaryotic translation initiation factor 4E</td><td align="left" rowspan="1" colspan="1">RNA binding; translation Factors; mTOR signaling pathway; insulin signaling pathway; translation; Hypertrophy model; cytoplasm; Insulin Signaling</td><td align="left" rowspan="1" colspan="1">BC087001</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Kif21a</td><td align="left" rowspan="1" colspan="1">kinesin family member 21A</td><td align="left" rowspan="1" colspan="1">microtubule cytoskeleton; cytoskeleton organization and biogenesis; motor activity</td><td align="left" rowspan="1" colspan="1">XM_217022</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Lgals8</td><td align="left" rowspan="1" colspan="1">lectin, galactose binding, soluble 8</td><td align="left" rowspan="1" colspan="1">sugar binding; carbohydrate binding</td><td align="left" rowspan="1" colspan="1">NM_053862</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Gdi2</td><td align="left" rowspan="1" colspan="1">GDP dissociation inhibitor 2</td><td align="left" rowspan="1" colspan="1">protein transport; GTPase regulator activity; vesicle-mediated transport</td><td align="left" rowspan="1" colspan="1">BC061767</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Igfbp1</td><td align="left" rowspan="1" colspan="1">insulin-like growth factor binding protein 1</td><td align="left" rowspan="1" colspan="1">extracellular region; cellular morphogenesis; morphogenesis; Smooth muscle contraction</td><td align="left" rowspan="1" colspan="1">BC078889</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Zmpste24</td><td align="left" rowspan="1" colspan="1">zinc metalloproteinase, STE24 homolog</td><td align="left" rowspan="1" colspan="1">metallopeptidase activity; adipogenesis</td><td align="left" rowspan="1" colspan="1">XM_233483</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Prkaa1</td><td align="left" rowspan="1" colspan="1">protein kinase, AMP-activated, alpha 1 catalytic subunit</td><td align="left" rowspan="1" colspan="1">fatty acid Synthesis; regulation of apoptosis; lipid biosynthesis; mTOR signaling pathway; energy derivation by oxidation of organic compounds; Insulin signaling pathway; protein serine threonine kinase activity; positive regulation of cellular process; negative regulation of cellular physiological process; negative regulation of cellular process; regulation of autophagy; adipocytokine signaling pathway; apoptosis; insulin signaling; regulation of programmed cell death; positive regulation of cellular physiological process</td><td align="left" rowspan="1" colspan="1">U40819</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Hnrpk</td><td align="left" rowspan="1" colspan="1">heterogeneous nuclear ribonucleoprotein K</td><td align="left" rowspan="1" colspan="1">mRNA processing reactome</td><td align="left" rowspan="1" colspan="1">D17711</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Gphn</td><td align="left" rowspan="1" colspan="1">Gephyrin</td><td align="left" rowspan="1" colspan="1">cytoskeleton; coenzyme metabolism; intracellular protein transport; cytoskeletal protein binding</td><td align="left" rowspan="1" colspan="1">X66366</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Mar-05</td><td align="left" rowspan="1" colspan="1">membrane-associated ring finger</td><td align="left" rowspan="1" colspan="1">ligase activity, forming carbon-nitrogen bonds; acid-amino acid ligase activity; ubiquitin cycle; ubiquitin-protein ligase activity; ubiquitin ligase complex; protein ubiquitination</td><td align="left" rowspan="1" colspan="1">XM_215286</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ptprc</td><td align="left" rowspan="1" colspan="1">protein tyrosine phosphatase, recipient type, C</td><td align="left" rowspan="1" colspan="1">phosphoric ester hydrolase activity; phosphoric monoester hydrolase activity</td><td align="left" rowspan="1" colspan="1">NM_001109890</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rgs1</td><td align="left" rowspan="1" colspan="1">regulator of G-protein signaling 1</td><td align="left" rowspan="1" colspan="1">signal transducer activity; negative regulation of cellular process; calcium regulation in cardiac cells; smooth muscle contraction</td><td align="left" rowspan="1" colspan="1">NM_019336</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cd86</td><td align="left" rowspan="1" colspan="1">CD86</td><td align="left" rowspan="1" colspan="1">cell adhesion molecules (CAMs);Toll-like recipient signaling pathway; inflammatory response pathway; type I diabetes mellitus</td><td align="left" rowspan="1" colspan="1">NM_020081</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M6pr</td><td align="left" rowspan="1" colspan="1">cation-dependent mannose-6-phosphate recipient</td><td align="left" rowspan="1" colspan="1">sugar binding; carbohydrate binding</td><td align="left" rowspan="1" colspan="1">BC079226</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Irak2</td><td align="left" rowspan="1" colspan="1">interleukin-1 recipient -associated kinase 2</td><td align="left" rowspan="1" colspan="1">apoptosis; protein serine threonine kinase activity; protein-tyrosine kinase activity</td><td align="left" rowspan="1" colspan="1">NM_001025422</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dnaja4</td><td align="left" rowspan="1" colspan="1">DnaJ (Hsp40) homolog, subfamily A, member 4 (predicted)</td><td align="left" rowspan="1" colspan="1">protein folding</td><td align="left" rowspan="1" colspan="1">BC082010</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Id2</td><td align="left" rowspan="1" colspan="1">Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein</td><td align="left" rowspan="1" colspan="1">positive regulation of cellular process; development; regulation of progression through cell cycle; TGF-beta signaling pathway; positive regulation of cellular physiological processes</td><td align="left" rowspan="1" colspan="1">BC086391</td></tr></tbody></table></alternatives></table-wrap><p>In the kidney transplantation groups, the internal milieu of the senior recipients caused upregulation of 127 and downregulation of 365 transcripts in young grafted kidneys (<xref ref-type="table" rid="pone-0065613-t004">table 4</xref>). The KEGG showed that the genes were clustered in the following pathways: MAPK signaling (6/218) and insulin signaling (3/113) (<xref ref-type="table" rid="pone-0065613-t003">Table 3</xref>).</p><p>The internal milieu of the young recipient rats upregulated 680 transcripts and downregulated 574 transcripts in senior grafted kidneys (<xref ref-type="table" rid="pone-0065613-t005">table 5</xref>). Using the KEGG, pathway analysis showed that the genes were again clustered in the MAPK signaling (8/218) and insulin signaling (9/113) pathways (<xref ref-type="table" rid="pone-0065613-t003">Table 3</xref>).</p></sec><sec id="s3c"><title>Real-time PCR Analysis of Selected Genes</title><p>The PCR results confirmed the expression of the four genes tested in the gene array analysis (<xref ref-type="table" rid="pone-0065613-t006">Table 6</xref>), SIRT-1, Connexin43, Irak2 and M6pr. SIRT-1 expression decreased significantly in young kidneys transplanted into senior recipients, and increased significantly in senior kidneys transplanted into young recipients. Connexin43 gene expression and gap junctions were significantly downregulated, and gap junctional intercellular communication activity was reduced, in old compared to young glomerular mesangial cells (GMCs). Irak2 and M6pr expression were not only consistent with changes in the natural aging process in young kidneys transplanted into senior recipients, but also showed reverse trends in senior kidneys transplanted into younger rats.</p><table-wrap id="pone-0065613-t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065613.t006</object-id><label>Table 6</label><caption><title>Gene expression in each group vs sham young/senior rats.</title></caption><alternatives><graphic id="pone-0065613-t006-6" xlink:href="pone.0065613.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Y-S/Y</td><td align="left" rowspan="1" colspan="1">S/Y</td><td align="left" rowspan="1" colspan="1">S-Y/S</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SIRT-1</td><td align="left" rowspan="1" colspan="1">Microarray</td><td align="left" rowspan="1" colspan="1">&#x02212;1.1</td><td align="left" rowspan="1" colspan="1">&#x02212;1.6</td><td align="left" rowspan="1" colspan="1">1.1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RealTime PCR</td><td align="left" rowspan="1" colspan="1">&#x02212;1.8</td><td align="left" rowspan="1" colspan="1">&#x02212;1.3</td><td align="left" rowspan="1" colspan="1">8.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Connexin43</td><td align="left" rowspan="1" colspan="1">Microarray</td><td align="left" rowspan="1" colspan="1">&#x02212;1.1</td><td align="left" rowspan="1" colspan="1">&#x02212;1.1</td><td align="left" rowspan="1" colspan="1">&#x02212;1.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RealTime PCR</td><td align="left" rowspan="1" colspan="1">&#x02212;1.6</td><td align="left" rowspan="1" colspan="1">&#x02212;1.3</td><td align="left" rowspan="1" colspan="1">&#x02212;2.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Irak2</td><td align="left" rowspan="1" colspan="1">Microarray</td><td align="left" rowspan="1" colspan="1">&#x02212;1.6</td><td align="left" rowspan="1" colspan="1">&#x02212;2.1</td><td align="left" rowspan="1" colspan="1">2.3</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RealTime PCR</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">&#x02212;1.3</td><td align="left" rowspan="1" colspan="1">4.58</td></tr><tr><td align="left" rowspan="1" colspan="1">M6pr</td><td align="left" rowspan="1" colspan="1">Microarray</td><td align="left" rowspan="1" colspan="1">&#x02212;1.1</td><td align="left" rowspan="1" colspan="1">&#x02212;2.1</td><td align="left" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RealTime PCR</td><td align="left" rowspan="1" colspan="1">&#x02212;1.1</td><td align="left" rowspan="1" colspan="1">&#x02212;1.3</td><td align="left" rowspan="1" colspan="1">2.6</td></tr></tbody></table></alternatives></table-wrap></sec></sec><sec id="s4"><title>Discussion</title><p>The main findings of our study were that: 1. kidney aging occurred in this KT model; 2. aging itself did not influence renal function after KT; 3. accumulation of oxidative stress may be related to the aging effects observed; 4. the change in gene expression profile was different in young and old rat kidneys; these changes were apparent in different pathways: energy metabolism, extracellular matrix (ECM), immunological inflammation, proliferation, differentiation, and apoptosis; 5. the p53-p21, MAPK and insulin signaling pathways may be involved in regulation of these responses. Moreover, Irak2 and M6pr were sensitive renal aging-associated genes.</p><p>Kidney aging was present in this KT model because the positive rate of staining for SA-&#x003b2;-gal was significantly higher in senior compared to young kidneys. SA-&#x003b2;-gal is a simple biomarker of replicative senescence <xref rid="pone.0065613-Dimri1" ref-type="bibr">[26]</xref>, <xref rid="pone.0065613-Sikora1" ref-type="bibr">[27]</xref>, and levels were significantly higher in the Y-S group than in the Y-Y group; in addition, levels were significantly lower in the S-Y group compared to those in the S-S group.</p><p>Kidney aging was not associated with significant changes in the GFR in our model, but there was a small change in the tubular mesenchymal score, suggesting a potential role of tubular pathogenesis in long-term ischemia/reperfusion injury. Our data are similar to some clinical observations, in which donor-recipient age difference was not associated with increased patient death, death-censored graft failure or serum creatinine at 5 or 10 years, nor was it associated with an increased risk of acute rejection within the first 6 months after KT <xref rid="pone.0065613-Ferrari1" ref-type="bibr">[28]</xref>. However, other clinical studies have shown that donor age, recipient age or donor-recipient age difference was associated with worse short-term or long-term outcomes after KT <xref rid="pone.0065613-Basar1" ref-type="bibr">[3]</xref>&#x02013;<xref rid="pone.0065613-Pascher1" ref-type="bibr">[10]</xref>. According a recent observational study including 6,317 KT patients, graft outcomes from recipients of older living donor kidneys were inferior to those obtained with younger living donors <xref rid="pone.0065613-Lim2" ref-type="bibr">[29]</xref>. These differences may be explained by the different patient populations included and the different criteria used to evaluate outcomes.</p><p>In cross-transplantation, the internal milieu in the young rats was associated with increased SOD activity and decreased MDA content in the grafted senior kidneys, whereas the milieu in the older rats had the reverse effect on the grafted young kidneys. SODs catalyze the conversion of (O<sub>2</sub>&#x02022;&#x02212;) to H<sub>2</sub>O<sub>2</sub>, which may participate in cell signaling. In addition, SODs play a critical role in inhibiting oxidative inactivation of nitric oxide, thereby preventing peroxynitrite formation and endothelial and mitochondrial dysfunction <xref rid="pone.0065613-Fukai1" ref-type="bibr">[30]</xref>. Malondialdehyde (MDA) is an end-product of lipid peroxidation and a side product of thromboxane A(2) synthesis. Moreover, it is a frequently measured biomarker of oxidative stress, but its high reactivity and toxicity underline the fact that this molecule is more than &#x0201c;just&#x0201d; a biomarker <xref rid="pone.0065613-Giera1" ref-type="bibr">[31]</xref>. Our observations indicate that the oxidative stress associated with aging may be ameliorated by the younger milieu. Free radicals injure proteins, DNA, biological membranes, mitochondria, and accelerate aging in vivo and in vitro <xref rid="pone.0065613-Barouki1" ref-type="bibr">[32]</xref>. Mitochondria are not only the main site of energy metabolism but also a major source of reactive oxygen species (ROS) <xref rid="pone.0065613-Wei1" ref-type="bibr">[33]</xref>. Mitochondrial function and morphology are impaired during aging, with a reduction in SOD and an increase in MDA <xref rid="pone.0065613-Bak1" ref-type="bibr">[34]</xref>, <xref rid="pone.0065613-Qiao1" ref-type="bibr">[35]</xref>. These changes result in the accumulation of oxidative stress with aging, rendering the mitochondria of older animals more susceptible to oxidative injury <xref rid="pone.0065613-Mather1" ref-type="bibr">[36]</xref>.</p><p>Compared with young rats, genes in the older rats were largely downregulated, in a manner similar to that seen in humans <xref rid="pone.0065613-Rodwell1" ref-type="bibr">[37]</xref>. Downregulation of the majority of genes indicates that various physiological functions decline in the rat kidney during the aging process. There were significant differences in gene expression between Y-S and S-Y groups, mostly involving the following pathways: Energy metabolism, extracellular matrix (ECM), immunological inflammation, proliferation, differentiation, and apoptosis. These pathways are very important during aging, and are functionally decreased during the aging process <xref rid="pone.0065613-Spallarossa1" ref-type="bibr">[38]</xref>&#x02013;<xref rid="pone.0065613-DSouza1" ref-type="bibr">[40]</xref>. MAPKs are highly conserved serine/threonine kinases that are activated in response to a wide variety of stimuli and play a role in numerous cell functions including survival, growth, and proliferation <xref rid="pone.0065613-Spallarossa2" ref-type="bibr">[41]</xref>. Ito et al. demonstrated that p38 regulates senescence and p16INK4A in hematopoietic stem cells <xref rid="pone.0065613-Ito1" ref-type="bibr">[42]</xref>. Zhang et al. showed that inhibiting the p38 pathway mitigates senescence in human umbilical cord blood Endothelial Progenitor Cells (EPCs) <xref rid="pone.0065613-Zhang1" ref-type="bibr">[43]</xref>. The insulin pathway mediates glucose intolerance, insulin resistance, and type 2 diabetes associated with aging, leading causes of morbidity and mortality, as well as increasing the risk of multiple other age-related diseases, such as cancer, stroke, cardiovascular diseases, Parkinson&#x02019;s disease, and Alzheimer&#x02019;s disease <xref rid="pone.0065613-Reaven1" ref-type="bibr">[44]</xref>.</p><p>Genes known to be associated with aging, such as SIRT-1, connexin 43, and genes expressed consistently with the age of recipients, such as Irak2 and M6pr, were selected for real-time PCR verification. SIRT-1 expression was significantly lower in the Y-S group, and significantly higher in the S-Y group. SIRT1 is critical to energy metabolism and senescence; it may induce the relative silence of chromatin by sensing cell NAD+ level, and is downregulated during aging <xref rid="pone.0065613-Longo1" ref-type="bibr">[45]</xref>. Activation of SIRT1 is associated with longevity and the attenuation of metabolic disorders. SIRT1 in the kidney is cytoprotective and participates in the regulation of blood pressure and sodium balance <xref rid="pone.0065613-Hao1" ref-type="bibr">[46]</xref>. The different expression of SIRT-1 protein observed in our study indicated that changes in the internal milieu were associated with activation or inactivation of epigenetic factors involved in the &#x02018;accelerated aging&#x02019; or &#x02018;reverse aging&#x02019; process. From the microarray data, we observed that the acetylation associated genes, such as PCAF, were involved in the effects of the internal environment on the grafted kidney. Hence, SIRT-1 was not acting alone. In addition, Irak2 and M6pr expression were not only consistent with changes in the natural aging process in young kidneys transplanted into senior recipients, but also showed the reverse trends in senior kidneys transplanted into younger rats. Irak2 plays a key role in tumor necrosis factor (TNF) recipient-associated factor-6 (TRAF-6)-mediated nuclear factor-&#x003ba;B (NF-&#x003ba;B) activation <xref rid="pone.0065613-Bowie1" ref-type="bibr">[47]</xref>. Aging results in dysregulation of both the innate and adaptive arms of the immune response <xref rid="pone.0065613-NikolichZugich1" ref-type="bibr">[48]</xref>, and the NF-&#x003ba;B/REL family of transcription factors plays a central role in coordinating the expression of a wide variety of genes that control immune responses <xref rid="pone.0065613-Li1" ref-type="bibr">[49]</xref>. Therefore, Irak2 may be an important factor in immune senescence. M6pr is a receptor of mannose-6-phosphate and insulin-like growth factor II (IGF-II), and is involved in the sorting of lysosomal enzymes and the clearance of IGF-II, which directly suppresses malignant cell proliferation <xref rid="pone.0065613-LeRoith1" ref-type="bibr">[50]</xref>, <xref rid="pone.0065613-Esseghir1" ref-type="bibr">[51]</xref>. As production of lysosomal enzymes declines with age, and as lysosomes engulf increasingly large aggregates of oxidized, glycated, cross-linked proteins, and lipids that are resistant to enzymatic degradation, dysfunctional lysosomes (bloated with indigestible contents) accumulate in cells as lipofuscin granules. In addition, the integrity of the autophagosomal&#x02013;lysosomal network appears to be critical in the progression of aging, and a progressive increase in intralysosomal concentrations of free radicals and the age pigment, lipofuscin, further diminish the efficiency of lysosomal protein degradation <xref rid="pone.0065613-Rajawat1" ref-type="bibr">[52]</xref>. The decline in M6pr may be associated with aging and may activate the malignant proliferation of cells. Connexin43 is a major connexin in GMCs, and our previous research indicated that connexin43 gene and protein expression, as well as gap junctions, are significantly downregulated, and that gap junctional intercellular communication activity is reduced, in old vs. young GMCs <xref rid="pone.0065613-Zhang2" ref-type="bibr">[53]</xref>. Both gene chip and real-time PCR analyses verified these genes expression trends.</p><p>There are several limitations of our study. First, our animals were healthy animals with their kidneys lack of kidney dysfunction, which is different from the clinical situation of patients with renal failure and other comorbidities. Second, the right native kidneys of the recipients were not removed, which would worsen the I/R injury and acute renal failure of the grafted kidney, and then influence the gene expression profile. Nevertheless, despite these limitations, we believe our results provide insight into possible genetic manipulation in KT patients.</p><sec id="s4a"><title>Conclusions</title><p>In summary, kidney graft aging was present in the current model. There was no difference in KT graft function between young and senior kidney cross-transplantation. Oxidative stress played an important role in kidney aging; the gene expression profile was significantly different in the Y-S compared to the S-Y groups, with differences found largely in the MAPK and insulin signaling pathways. Further studies are warranted to investigate the aging difference in the kidney dysfunction model after KT and Genetic manipulation may be a potential option of ameliorating kidney aging on KT outcomes.</p></sec></sec></body><back><ref-list><title>References</title><ref id="pone.0065613-Health1"><label>1</label><mixed-citation publication-type="other">Health Resources and Services Administration website. Available: <ext-link ext-link-type="uri" xlink:href="http://Http://optn.transplant.hrsa.gov/ar2009/209_age_dc.htm?o=2&#x00026;g=5&#x00026;c=0">Http://optn.transplant.hrsa.gov/ar2009/209_age_dc.htm?o=2&#x00026;g=5&#x00026;c=0</ext-link>. Accessed 2009 May 4.</mixed-citation></ref><ref id="pone.0065613-Health2"><label>2</label><mixed-citation publication-type="other">Health Resources and Services Administration website. Available: <ext-link ext-link-type="uri" xlink:href="http://optn.transplant.hrsa.gov/ar2009/504c_age_ki.htm">http://optn.transplant.hrsa.gov/ar2009/504c_age_ki.htm</ext-link>. Accessed 2009 May 4.</mixed-citation></ref><ref id="pone.0065613-Basar1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Basar</surname><given-names>H</given-names></name>, <name><surname>Soran</surname><given-names>A</given-names></name>, <name><surname>Shapiro</surname><given-names>R</given-names></name>, <name><surname>Vivas</surname><given-names>C</given-names></name>, <name><surname>Scantlebury</surname><given-names>VP</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Renal transplantation in recipients over the age of 60: the impact of donor age</article-title>. <source>Transplantation</source>
<volume>67</volume>: <fpage>1191</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">10232574</pub-id></mixed-citation></ref><ref id="pone.0065613-Keith1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Keith</surname><given-names>DS</given-names></name>, <name><surname>Demattos</surname><given-names>A</given-names></name>, <name><surname>Golconda</surname><given-names>M</given-names></name>, <name><surname>Prather</surname><given-names>J</given-names></name>, <name><surname>Norman</surname><given-names>D</given-names></name> (<year>2004</year>) <article-title>Effect of donor recipient age match on survival after first deceased donor renal transplantation</article-title>. <source>J Am Soc Nephrol</source>
<volume>15</volume>: <fpage>1086</fpage>&#x02013;<lpage>1091</lpage>.<pub-id pub-id-type="pmid">15034113</pub-id></mixed-citation></ref><ref id="pone.0065613-Waiser1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Waiser</surname><given-names>J</given-names></name>, <name><surname>Schreiber</surname><given-names>M</given-names></name>, <name><surname>Budde</surname><given-names>K</given-names></name>, <name><surname>Fritsche</surname><given-names>L</given-names></name>, <name><surname>B&#x000f6;hler</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Age-matching in renal transplantation</article-title>. <source>Nephrol Dial Transplant</source>
<volume>15</volume>: <fpage>696</fpage>&#x02013;<lpage>700</lpage>.<pub-id pub-id-type="pmid">10809813</pub-id></mixed-citation></ref><ref id="pone.0065613-Lim1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Lim</surname><given-names>WH</given-names></name>, <name><surname>Chang</surname><given-names>S</given-names></name>, <name><surname>Chadban</surname><given-names>S</given-names></name>, <name><surname>Campbell</surname><given-names>S</given-names></name>, <name><surname>Dent</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Donor-recipient age matching improves years of graft function in deceased-donor kidney transplantation</article-title>. <source>Nephrol Dial Transplant</source>
<volume>25</volume>: <fpage>3082</fpage>&#x02013;<lpage>3089</lpage>.<pub-id pub-id-type="pmid">20736266</pub-id></mixed-citation></ref><ref id="pone.0065613-Jassal1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Jassal</surname><given-names>SV</given-names></name>, <name><surname>Opelz</surname><given-names>G</given-names></name>, <name><surname>Cole</surname><given-names>E</given-names></name> (<year>1997</year>) <article-title>Transplantation in the elderly: a review</article-title>. <source>Geriatr Nephrol Urol</source>
<volume>7</volume>: <fpage>157</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">9493037</pub-id></mixed-citation></ref><ref id="pone.0065613-Fan1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Fan</surname><given-names>PY</given-names></name>, <name><surname>Ashby</surname><given-names>VB</given-names></name>, <name><surname>Fuller</surname><given-names>DS</given-names></name>, <name><surname>Boulware</surname><given-names>LE</given-names></name>, <name><surname>Kao</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Access and outcomes among minority transplant patients, 1999&#x02013;2008, with a focus on determinants of kidney graft survival</article-title>. <source>Am J Transplant</source>
<volume>10</volume>: <fpage>1090</fpage>&#x02013;<lpage>1107</lpage>.<pub-id pub-id-type="pmid">20420655</pub-id></mixed-citation></ref><ref id="pone.0065613-Donnelly1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Donnelly</surname><given-names>P</given-names></name>, <name><surname>Veitch</surname><given-names>P</given-names></name>, <name><surname>Bell</surname><given-names>P</given-names></name>, <name><surname>Henderson</surname><given-names>R</given-names></name>, <name><surname>Oman</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>1991</year>) <article-title>Donor-recipient age difference&#x02013;an independent risk factor in cyclosporin-treated renal transplant recipients</article-title>. <source>Transpl Int</source>
<volume>4</volume>: <fpage>88</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">1910435</pub-id></mixed-citation></ref><ref id="pone.0065613-Pascher1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Pascher</surname><given-names>A</given-names></name>, <name><surname>Pratschke</surname><given-names>J</given-names></name>, <name><surname>Neuhaus</surname><given-names>P</given-names></name>, <name><surname>Tullius</surname><given-names>SG</given-names></name> (<year>2004</year>) <article-title>Modifications of immune regulations with increasing donor &#x00026; recipient age</article-title>. <source>Ann Transplant</source>
<volume>9</volume>: <fpage>72</fpage>&#x02013;<lpage>73</lpage>.</mixed-citation></ref><ref id="pone.0065613-Lane1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Lane</surname><given-names>N</given-names></name> (<year>2003</year>) <article-title>A unifying view of ageing and disease: the double-agent theory</article-title>. <source>J Theor Biol</source>
<volume>225</volume>: <fpage>531</fpage>&#x02013;<lpage>540</lpage>.<pub-id pub-id-type="pmid">14615212</pub-id></mixed-citation></ref><ref id="pone.0065613-Kolodziej1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Kolodziej</surname><given-names>S</given-names></name>, <name><surname>Marzinzig</surname><given-names>M</given-names></name>, <name><surname>Schneider</surname><given-names>A</given-names></name>, <name><surname>Mayer</surname><given-names>JM</given-names></name> (<year>2004</year>) <article-title>Severe dysbalance of antioxidative capacity in older recipients is associated with poorer outcome in kidney transplantation</article-title>. <source>Am J Transplant</source>
<volume>4</volume>: <fpage>428</fpage>.</mixed-citation></ref><ref id="pone.0065613-LaManna1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>La Manna</surname><given-names>G</given-names></name>, <name><surname>Lanci</surname><given-names>N</given-names></name>, <name><surname>Della Bella</surname><given-names>E</given-names></name>, <name><surname>Comai</surname><given-names>G</given-names></name>, <name><surname>Cappuccilli</surname><given-names>ML</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Reduction of oxidative damage reflects a better kidney transplantation outcome</article-title>. <source>Am J Nephrol</source>
<volume>34</volume>: <fpage>496</fpage>&#x02013;<lpage>504</lpage>.<pub-id pub-id-type="pmid">22041478</pub-id></mixed-citation></ref><ref id="pone.0065613-Kainz1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Kainz</surname><given-names>A</given-names></name>, <name><surname>Perco</surname><given-names>P</given-names></name>, <name><surname>Mayer</surname><given-names>B</given-names></name>, <name><surname>Soleiman</surname><given-names>A</given-names></name>, <name><surname>Steininger</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function</article-title>. <source>Transplantation</source>
<volume>83</volume>: <fpage>1048</fpage>&#x02013;<lpage>1054</lpage>.<pub-id pub-id-type="pmid">17452894</pub-id></mixed-citation></ref><ref id="pone.0065613-Brouard1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Brouard</surname><given-names>S</given-names></name>, <name><surname>Giral</surname><given-names>M</given-names></name>, <name><surname>Soulillou</surname><given-names>JP</given-names></name>, <name><surname>Ashton-Chess</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>Elaboration of gene expression-based clinical decision aids for kidney transplantation: where do we stand?</article-title>
<source>Transplantation</source>
<volume>91</volume>: <fpage>691</fpage>&#x02013;<lpage>696</lpage>.<pub-id pub-id-type="pmid">21283062</pub-id></mixed-citation></ref><ref id="pone.0065613-Tullius1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Tullius</surname><given-names>SG</given-names></name>, <name><surname>Nieminen</surname><given-names>M</given-names></name>, <name><surname>Bechstein</surname><given-names>WO</given-names></name>, <name><surname>Jonas</surname><given-names>S</given-names></name>, <name><surname>Steinm&#x000fc;ller</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model</article-title>. <source>Kidney Int</source>
<volume>53</volume>: <fpage>465</fpage>&#x02013;<lpage>472</lpage>.<pub-id pub-id-type="pmid">9461108</pub-id></mixed-citation></ref><ref id="pone.0065613-McLigeyo1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>McLigeyo</surname><given-names>SO</given-names></name> (<year>1993</year>) <article-title>Calculation of creatinine clearance from plasma creatinine</article-title>. <source>East Afr Med J</source>
<volume>70</volume>: <fpage>3</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="pone.0065613-Krishnamurthy1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Krishnamurthy</surname><given-names>J</given-names></name>, <name><surname>Torrice</surname><given-names>C</given-names></name>, <name><surname>Ramsey</surname><given-names>MR</given-names></name>, <name><surname>Kovalev</surname><given-names>GI</given-names></name>, <name><surname>Al-Regaiey</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Ink4a/Arf expression is a biomarker of aging</article-title>. <source>J Clin Invest</source>
<volume>114</volume>: <fpage>1299</fpage>&#x02013;<lpage>1307</lpage>.<pub-id pub-id-type="pmid">15520862</pub-id></mixed-citation></ref><ref id="pone.0065613-Sasaki1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Sasaki</surname><given-names>T</given-names></name>, <name><surname>Maier</surname><given-names>B</given-names></name>, <name><surname>Bartke</surname><given-names>A</given-names></name>, <name><surname>Scrable</surname><given-names>H</given-names></name> (<year>2006</year>) <article-title>Progressive loss of SIRT1 with cell cycle withdrawal</article-title>. <source>Aging Cell</source>
<volume>5</volume>: <fpage>413</fpage>&#x02013;<lpage>422</lpage>.<pub-id pub-id-type="pmid">16939484</pub-id></mixed-citation></ref><ref id="pone.0065613-Guo1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Guo</surname><given-names>Y</given-names></name>, <name><surname>Guo</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Xie</surname><given-names>H</given-names></name>, <name><surname>Zhao</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells</article-title>. <source>J Virol</source>
<volume>79</volume>: <fpage>14392</fpage>&#x02013;<lpage>14403</lpage>.<pub-id pub-id-type="pmid">16254373</pub-id></mixed-citation></ref><ref id="pone.0065613-Patterson1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Patterson</surname><given-names>TA</given-names></name>, <name><surname>Lobenhofer</surname><given-names>EK</given-names></name>, <name><surname>Fulmer-Smentek</surname><given-names>SB</given-names></name>, <name><surname>Collins</surname><given-names>PJ</given-names></name>, <name><surname>Chu</surname><given-names>TM</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project</article-title>. <source>Nat Biotechnol</source>
<volume>24</volume>: <fpage>1140</fpage>&#x02013;<lpage>1150</lpage>.<pub-id pub-id-type="pmid">16964228</pub-id></mixed-citation></ref><ref id="pone.0065613-VanGelder1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Van Gelder</surname><given-names>RN</given-names></name>, <name><surname>von Zastrow</surname><given-names>ME</given-names></name>, <name><surname>Yool</surname><given-names>A</given-names></name>, <name><surname>Dement</surname><given-names>WC</given-names></name>, <name><surname>Barchas</surname><given-names>JD</given-names></name>, <etal>et al</etal> (<year>1990</year>) <article-title>Amplified RNA synthesized from limited quantities of heterogeneous cDNA</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>87</volume>: <fpage>1663</fpage>&#x02013;<lpage>1667</lpage>.<pub-id pub-id-type="pmid">1689846</pub-id></mixed-citation></ref><ref id="pone.0065613-Yang1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>YH</given-names></name>, <name><surname>Dudoit</surname><given-names>S</given-names></name>, <name><surname>Luu</surname><given-names>P</given-names></name>, <name><surname>Lin</surname><given-names>DM</given-names></name>, <name><surname>Peng</surname><given-names>V</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation</article-title>. <source>Nucleic Acids Res</source>
<volume>30</volume>: <fpage>e15</fpage>.<pub-id pub-id-type="pmid">11842121</pub-id></mixed-citation></ref><ref id="pone.0065613-Pfaffl1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Pfaffl</surname><given-names>MW</given-names></name> (<year>2001</year>) <article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title>. <source>Nucleic Acids Res</source>
<volume>29</volume>: <fpage>e45</fpage>.<pub-id pub-id-type="pmid">11328886</pub-id></mixed-citation></ref><ref id="pone.0065613-Tusher1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Tusher</surname><given-names>VG</given-names></name>, <name><surname>Tibshirani</surname><given-names>R</given-names></name>, <name><surname>Chu</surname><given-names>G</given-names></name> (<year>2001</year>) <article-title>Significance analysis of microarrays applied to the ionizing radiation response</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>98</volume>: <fpage>5116</fpage>&#x02013;<lpage>5121</lpage>.<pub-id pub-id-type="pmid">11309499</pub-id></mixed-citation></ref><ref id="pone.0065613-Dimri1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Dimri</surname><given-names>GP</given-names></name>, <name><surname>Lee</surname><given-names>X</given-names></name>, <name><surname>Basile</surname><given-names>G</given-names></name>, <name><surname>Acosta</surname><given-names>M</given-names></name>, <name><surname>Scott</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>1995</year>) <article-title>A biomarker that identifies senescent human cells in culture and in aging skin in vivo</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>92</volume>: <fpage>9363</fpage>&#x02013;<lpage>9367</lpage>.<pub-id pub-id-type="pmid">7568133</pub-id></mixed-citation></ref><ref id="pone.0065613-Sikora1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Sikora</surname><given-names>E</given-names></name>, <name><surname>Arendt</surname><given-names>T</given-names></name>, <name><surname>Bennett</surname><given-names>M</given-names></name>, <name><surname>Narita</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Impact of cellular senescence signature on ageing research</article-title>. <source>Ageing Res Rev</source>
<volume>10</volume>: <fpage>146</fpage>&#x02013;<lpage>152</lpage>.<pub-id pub-id-type="pmid">20946972</pub-id></mixed-citation></ref><ref id="pone.0065613-Ferrari1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Ferrari</surname><given-names>P</given-names></name>, <name><surname>Lim</surname><given-names>W</given-names></name>, <name><surname>Dent</surname><given-names>H</given-names></name>, <name><surname>McDonald</surname><given-names>SP</given-names></name> (<year>2011</year>) <article-title>McDonald. Effect of donor-recipient age difference on graft function and survival in live-donor kidney transplantation</article-title>. <source>Nephrol Dial Transplant</source>
<volume>26</volume>: <fpage>702</fpage>&#x02013;<lpage>708</lpage>.<pub-id pub-id-type="pmid">20601369</pub-id></mixed-citation></ref><ref id="pone.0065613-Lim2"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Lim</surname><given-names>WH</given-names></name>, <name><surname>Clayton</surname><given-names>P</given-names></name>, <name><surname>Wong</surname><given-names>G</given-names></name>, <name><surname>Campbell</surname><given-names>SB</given-names></name>, <name><surname>Cohney</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Outcomes of kidney transplantation from older living donors</article-title>. <source>Transplantation</source>
<volume>95</volume>: <fpage>106</fpage>&#x02013;<lpage>113</lpage>.<pub-id pub-id-type="pmid">23263504</pub-id></mixed-citation></ref><ref id="pone.0065613-Fukai1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Fukai</surname><given-names>T</given-names></name>, <name><surname>Ushio-Fukai</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Superoxide dismutases: role in redox signaling, vascular function, and diseases</article-title>. <source>Antioxid Redox Signal</source>
<volume>15</volume>: <fpage>1583</fpage>&#x02013;<lpage>1606</lpage>.<pub-id pub-id-type="pmid">21473702</pub-id></mixed-citation></ref><ref id="pone.0065613-Giera1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Giera</surname><given-names>M</given-names></name>, <name><surname>Lingeman</surname><given-names>H</given-names></name>, <name><surname>Niessen</surname><given-names>WM</given-names></name> (<year>2012</year>) <article-title>Recent Advancements in the LC- and GC-Based Analysis of Malondialdehyde (MDA): A Brief Overview</article-title>. <source>Chromatographia</source>
<volume>75</volume>: <fpage>433</fpage>&#x02013;<lpage>440</lpage>.<pub-id pub-id-type="pmid">22593603</pub-id></mixed-citation></ref><ref id="pone.0065613-Barouki1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Barouki</surname><given-names>R</given-names></name> (<year>2006</year>) <article-title>Ageing free radicals and cellular stress</article-title>. <source>Med Sci (Paris)</source>
<volume>22</volume>: <fpage>266</fpage>&#x02013;<lpage>272</lpage>.<pub-id pub-id-type="pmid">16527207</pub-id></mixed-citation></ref><ref id="pone.0065613-Wei1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Wei</surname><given-names>YH</given-names></name>, <name><surname>Lee</surname><given-names>HC</given-names></name> (<year>2002</year>) <article-title>Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging</article-title>. <source>Exp Biol Med (Maywood)</source>
<volume>227</volume>: <fpage>671</fpage>&#x02013;<lpage>682</lpage>.<pub-id pub-id-type="pmid">12324649</pub-id></mixed-citation></ref><ref id="pone.0065613-Bak1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Bak</surname><given-names>MI</given-names></name>, <name><surname>Wei</surname><given-names>JY</given-names></name>, <name><surname>Ingwall</surname><given-names>JS</given-names></name> (<year>1998</year>) <article-title>Interaction of hypoxia and aging in the heart: analysis of high energy phosphate content</article-title>. <source>J Mol Cell Cardiol</source>
<volume>30</volume>: <fpage>661</fpage>&#x02013;<lpage>672</lpage>.<pub-id pub-id-type="pmid">9515041</pub-id></mixed-citation></ref><ref id="pone.0065613-Qiao1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Qiao</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Ding</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Mitochondrial pathway is responsible for aging-related increase of tubular cell apoptosis in renal ischemia/reperfusion injury</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>
<volume>60</volume>: <fpage>830</fpage>&#x02013;<lpage>839</lpage>.<pub-id pub-id-type="pmid">16079204</pub-id></mixed-citation></ref><ref id="pone.0065613-Mather1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Mather</surname><given-names>M</given-names></name>, <name><surname>Rottenberg</surname><given-names>H</given-names></name> (<year>2000</year>) <article-title>Aging enhances the activation of the permeability transition pore in mitochondria</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>273</volume>: <fpage>603</fpage>&#x02013;<lpage>608</lpage>.<pub-id pub-id-type="pmid">10873652</pub-id></mixed-citation></ref><ref id="pone.0065613-Rodwell1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Rodwell</surname><given-names>GE</given-names></name>, <name><surname>Sonu</surname><given-names>R</given-names></name>, <name><surname>Zahn</surname><given-names>JM</given-names></name>, <name><surname>Lund</surname><given-names>J</given-names></name>, <name><surname>Wilhelmy</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>A transcriptional profile of aging in the human kidney</article-title>. <source>PLoS Biol</source>
<volume>2</volume>: <fpage>e427</fpage>.<pub-id pub-id-type="pmid">15562319</pub-id></mixed-citation></ref><ref id="pone.0065613-Spallarossa1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Spallarossa</surname><given-names>P</given-names></name>, <name><surname>Altieri</surname><given-names>P</given-names></name>, <name><surname>Barisione</surname><given-names>C</given-names></name>, <name><surname>Passalacqua</surname><given-names>M</given-names></name>, <name><surname>Aloi</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells</article-title>. <source>PLoS One</source>
<volume>5</volume>: <fpage>e15583</fpage>.<pub-id pub-id-type="pmid">21187925</pub-id></mixed-citation></ref><ref id="pone.0065613-Gong1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Gong</surname><given-names>Z</given-names></name>, <name><surname>Muzumdar</surname><given-names>RH</given-names></name> (<year>2012</year>) <article-title>Pancreatic function, type 2 diabetes, and metabolism in aging</article-title>. <source>Int J Endocrinol</source>
<volume>2012</volume>: <fpage>320482</fpage>.<pub-id pub-id-type="pmid">22675349</pub-id></mixed-citation></ref><ref id="pone.0065613-DSouza1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>D&#x02019;Souza</surname><given-names>T</given-names></name>, <name><surname>Sherman-Baust</surname><given-names>CA</given-names></name>, <name><surname>Poosala</surname><given-names>S</given-names></name>, <name><surname>Mullin</surname><given-names>JM</given-names></name>, <name><surname>Morin</surname><given-names>PJ</given-names></name> (<year>2009</year>) <article-title>Age-related changes of claudin expression in mouse liver, kidney, and pancreas</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>
<volume>64</volume>: <fpage>1146</fpage>&#x02013;<lpage>1153</lpage>.<pub-id pub-id-type="pmid">19692671</pub-id></mixed-citation></ref><ref id="pone.0065613-Spallarossa2"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Spallarossa</surname><given-names>P</given-names></name>, <name><surname>Altieri</surname><given-names>P</given-names></name>, <name><surname>Aloi</surname><given-names>C</given-names></name>, <name><surname>Garibaldi</surname><given-names>S</given-names></name>, <name><surname>Barisione</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2</article-title>. <source>Am J Physiol Heart Circ Physiol</source>
<volume>297</volume>: <fpage>H2169</fpage>&#x02013;<lpage>H2181</lpage>.<pub-id pub-id-type="pmid">19801496</pub-id></mixed-citation></ref><ref id="pone.0065613-Ito1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Ito</surname><given-names>K</given-names></name>, <name><surname>Hirao</surname><given-names>A</given-names></name>, <name><surname>Arai</surname><given-names>F</given-names></name>, <name><surname>Takubo</surname><given-names>K</given-names></name>, <name><surname>Matsuoka</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells</article-title>. <source>Nat Med</source>
<volume>12</volume>: <fpage>446</fpage>&#x02013;<lpage>451</lpage>.<pub-id pub-id-type="pmid">16565722</pub-id></mixed-citation></ref><ref id="pone.0065613-Zhang1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Herbert</surname><given-names>BS</given-names></name>, <name><surname>Rajashekhar</surname><given-names>G</given-names></name>, <name><surname>Ingram</surname><given-names>DA</given-names></name>, <name><surname>Yoder</surname><given-names>MC</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway</article-title>. <source>Faseb J</source>
<volume>23</volume>: <fpage>1358</fpage>&#x02013;<lpage>1365</lpage>.<pub-id pub-id-type="pmid">19124561</pub-id></mixed-citation></ref><ref id="pone.0065613-Reaven1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Reaven</surname><given-names>GM</given-names></name>, <name><surname>Chen</surname><given-names>YD</given-names></name> (<year>1988</year>) <article-title>Role of insulin in regulation of lipoprotein metabolism in diabetes</article-title>. <source>Diabetes Metab Rev</source>
<volume>4</volume>: <fpage>639</fpage>&#x02013;<lpage>652</lpage>.<pub-id pub-id-type="pmid">3069396</pub-id></mixed-citation></ref><ref id="pone.0065613-Longo1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Longo</surname><given-names>VD</given-names></name>, <name><surname>Kennedy</surname><given-names>BK</given-names></name> (<year>2006</year>) <article-title>Sirtuins in aging and age-related disease</article-title>. <source>Cell</source>
<volume>126</volume>: <fpage>257</fpage>&#x02013;<lpage>268</lpage>.<pub-id pub-id-type="pmid">16873059</pub-id></mixed-citation></ref><ref id="pone.0065613-Hao1"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Hao</surname><given-names>CM</given-names></name>, <name><surname>Haase</surname><given-names>VH</given-names></name> (<year>2010</year>) <article-title>Sirtuins and their relevance to the kidney</article-title>. <source>J Am Soc Nephrol</source>
<volume>21</volume>: <fpage>1620</fpage>&#x02013;<lpage>1627</lpage>.<pub-id pub-id-type="pmid">20595677</pub-id></mixed-citation></ref><ref id="pone.0065613-Bowie1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Bowie</surname><given-names>AG</given-names></name> (<year>2008</year>) <article-title>Insights from vaccinia virus into Toll-like receptor signalling proteins and their regulation by ubiquitin: role of IRAK-2</article-title>. <source>Biochem Soc Trans</source>
<volume>36</volume>: <fpage>449</fpage>&#x02013;<lpage>452</lpage>.<pub-id pub-id-type="pmid">18481979</pub-id></mixed-citation></ref><ref id="pone.0065613-NikolichZugich1"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Nikolich-Zugich</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>T cell aging: naive but not young</article-title>. <source>J Exp Med</source>
<volume>201</volume>: <fpage>837</fpage>&#x02013;<lpage>840</lpage>.<pub-id pub-id-type="pmid">15781575</pub-id></mixed-citation></ref><ref id="pone.0065613-Li1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Verma</surname><given-names>IM</given-names></name> (<year>2002</year>) <article-title>NF-kappaB regulation in the immune system</article-title>. <source>Nat Rev Immunol</source>
<volume>2</volume>: <fpage>725</fpage>&#x02013;<lpage>734</lpage>.<pub-id pub-id-type="pmid">12360211</pub-id></mixed-citation></ref><ref id="pone.0065613-LeRoith1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>LeRoith</surname><given-names>D</given-names></name>, <name><surname>Werner</surname><given-names>H</given-names></name>, <name><surname>Beitner-Johnson</surname><given-names>D</given-names></name>, <name><surname>Roberts</surname><given-names>CT</given-names><suffix>Jr</suffix></name> (<year>1995</year>) <article-title>Molecular and cellular aspects of the insulin-like growth factor I receptor</article-title>. <source>Endocr Rev</source>
<volume>16</volume>: <fpage>143</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">7540132</pub-id></mixed-citation></ref><ref id="pone.0065613-Esseghir1"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Esseghir</surname><given-names>S</given-names></name>, <name><surname>Reis-Filho</surname><given-names>JS</given-names></name>, <name><surname>Kennedy</surname><given-names>A</given-names></name>, <name><surname>James</surname><given-names>M</given-names></name>, <name><surname>O&#x02019;Hare</surname><given-names>MJ</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts</article-title>. <source>J Pathol</source>
<volume>210</volume>: <fpage>420</fpage>&#x02013;<lpage>430</lpage>.<pub-id pub-id-type="pmid">17054309</pub-id></mixed-citation></ref><ref id="pone.0065613-Rajawat1"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Rajawat</surname><given-names>YS</given-names></name>, <name><surname>Hilioti</surname><given-names>Z</given-names></name>, <name><surname>Bossis</surname><given-names>I</given-names></name> (<year>2009</year>) <article-title>Aging: central role for autophagy and the lysosomal degradative system</article-title>. <source>Ageing Res Rev</source>
<volume>8</volume>: <fpage>199</fpage>&#x02013;<lpage>213</lpage>.<pub-id pub-id-type="pmid">19427410</pub-id></mixed-citation></ref><ref id="pone.0065613-Zhang2"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Downregulation of connexin 43 expression by high glucose induces senescence in glomerular mesangial cells</article-title>. <source>J Am Soc Nephrol</source>
<volume>17</volume>: <fpage>1532</fpage>&#x02013;<lpage>1542</lpage>.<pub-id pub-id-type="pmid">16675599</pub-id></mixed-citation></ref></ref-list></back></article>